In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Abbott Laboratories (ABT – Research ...

This was the stock's fourth consecutive day of losses.

Shares of Abbott Laboratories ABT slid 3.42% to $132.66 Tuesday, on what proved to be an all-around rough trading session for ...

Abbott Laboratories recently experienced a 20% price increase over the last quarter. This uptick coincides with several noteworthy developments, including Abbott's collaboration with Cadrenal ...

Abbott Laboratories' (NYSE:ABT) stock is up by a considerable 21% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we decided to study the company ...

Abbott Laboratories (NYSE:ABT – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday after Citigroup raised their price target on the stock from $135.00 to $ ...

During the last three months, 8 analysts shared their evaluations of Abbott Laboratories ABT, revealing diverse outlooks from bullish to bearish. The table below provides a concise overview of ...

High-rolling investors have positioned themselves bullish on Abbott Laboratories ABT, and it's important for retail traders to take note. \This activity came to our attention today through ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 10 trades. If we ...

Abbott Laboratories (NYSE:ABT) shares closed flat at $135.87 on Thursday, after gaining for six straight sessions. The diagnostics company gained about 3% in the preceding six sessions.